Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.0615
Abstract: This systematic review and meta-analysis evaluates whether, for patients with poorly controlled asthma, switching to single inhaler combination budesonide-formoterol maintenance and reliever therapy is associated with longer time to first severe asthma exacerbation compared with… read more here.
Keywords: poorly controlled; maintenance; patients poorly; controlled asthma ... See more keywords
Bronchodilator reliever use and its association with the economic and humanistic burden of COPD: a propensity-matched study
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Medical Economics"
DOI: 10.1080/13696998.2016.1223085
Abstract: Abstract Background and aims: Short-acting bronchodilators are normally used as supplemental relief medication for breakthrough symptoms in COPD patients. The objective of this cross-sectional study was to assess if more frequent vs infrequent use of… read more here.
Keywords: reliever use; use; reliever; copd ... See more keywords
As-needed inhaled corticosteroids as add-on therapy versus SMART therapy: an evolving understanding of the two approaches in the management of moderate-to-severe asthma
Sign Up to like & getrecommendations! Published in 2023 at "Current Opinion in Pulmonary Medicine"
DOI: 10.1097/mcp.0000000000000961
Abstract: Purpose of review Asthma is the most common chronic respiratory disorder, characterized by recurring, reversible airflow obstruction due to inflammation and airway hyperresponsiveness. Although biologics have provided significant advances in the treatment of asthma, they… read more here.
Keywords: approaches management; therapy; moderate severe; severe asthma ... See more keywords
What matters most to patients when choosing treatment for mild–moderate asthma? Results from a discrete choice experiment
Sign Up to like & getrecommendations! Published in 2020 at "Thorax"
DOI: 10.1136/thoraxjnl-2019-214343
Abstract: Background An as-needed combination preventer and reliever regimen was recently introduced as an alternative to conventional daily preventer treatment for mild asthma. In a subgroup analysis of the PRACTICAL study, a pragmatic randomised controlled trial… read more here.
Keywords: treatment; reliever; study; treatment mild ... See more keywords
Over-the-counter Dispensing: Widening Access to Inhaled Corticosteroid/Formoterol Reliever Therapy
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Respiratory and Critical Care Medicine"
DOI: 10.1164/rccm.202212-2297ed
Abstract: The limited availability of low-dose inhaled corticosteroid (ICS)/formoterol reliever therapy in many countries is an issue of international concern. As recommended by the GINA (Global Initiative for Asthma) strategy, ICS/formoterol is preferred to short-acting b2… read more here.
Keywords: ics formoterol; reliever therapy; reliever; formoterol reliever ... See more keywords
Variability in airway inflammation, symptoms, lung function and reliever use in asthma: anti-inflammatory reliever hypothesis and STIFLE study design
Sign Up to like & getrecommendations! Published in 2020 at "ERJ Open Research"
DOI: 10.1183/23120541.00333-2019
Abstract: Asthma is a chronic inflammatory airway disease. Increase in airway inflammation is hypothesised to contribute to worsening of asthma symptoms and deterioration in lung function, resulting in the use of reliever medication. Short-acting β2-agonists only… read more here.
Keywords: anti inflammatory; inflammation; reliever; airway inflammation ... See more keywords